A growing body of evidence suggests that prolonged, strenuous exercise may result in the appearance of cardiac troponins (cTns; cTn, cTnT and/or cTnI), which are highly specific biomarkers of cardiomyocyte insult.
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Though there has been no consensus as to the mechanisms or clinical relevance of such findings, the universal increases in cTn even during routine training in athletes suggest that the phenomenon, in most cases, is physiological. 1 However, it is pertinent to note that even highly trained athletes are not 'protected' from exercise-related sudden cardiac death; 2 thus, the ability to assess athletes appropriately is helped by discriminating the physiological and pathological cTn responses to prolonged exercise bouts.
A recent article, published in the European Journal of Preventive Cardiology (EJPC), by Skadberg et al. 3 offers an important contribution to our knowledge on this topic, identifying participants with highly elevated cTn after prolonged, strenuous exercise, and evaluating these for subclinical coronary artery disease (CAD). The findings from this study suggest the presence of a pathological exercise-induced cTnI response in recreational athletes with silent CAD. Further, authors emphasised that if an exercise-induced cTn-based cutoff value for CAD can be verified in future prospective trials, it may suggest a potential role for cTn in the detection of subclinical CAD in athletes participating in endurance sports.
The present report has important clinical relevance, given that even Olympic athletes, despite the absence of symptoms or astonishing fitness, are not immune from CAD. 2 However, studies have reported multiple different factors influencing post-exercise levels of cTn, 1 thus substantial inter-individual variability noted in cTn response may complicate the cTn cut-off value following exercise that may represent CAD. For instance, in our recent well-controlled study, 4 adolescents demonstrated that a peak of cTnT occurred at 3 h post-exercise that was 11 times higher than in adults (median (range): 211.0 (11.2-794.5) vs 19.1 (9.7-305.6) ng/l) after a long-distance run. The findings suggest that the magnitude of exercise-induced increases in cTnT levels may be influenced by the age and/or maturity status of an individual. Therefore, the cut-off value of cTnT responses to exercise for CAD should be much higher in adolescents than in adults. Further, we [5] [6] [7] and others 8 have also demonstrated that training experience, sex and environmental strain may relate to the exercise-induced increase in cTn. Therefore, use of a single, fixed cut-off value as a reference might not be appropriate for athletes being evaluated for CAD with the blood indices of cTn following strenuous exercise. In further investigations, the pathological exerciseinduced cut-off value of cTn should be stratified according to the certain factors of influence for optimising diagnosis of subclinical CAD in athletes.
It is noteworthy that, until now, the magnitude of exercise-induced cTn release can only be partially explained by the known parameters above; 6 additional factors still need to be considered. Beyond the observations in sports settings, related clinical studies also need to be noted, which may provide some clues that could guide future work. Specifically, two articles 9,10 recently published in the EJPC, provided important implications for this purpose. The first paper by Pokharel et al. 9 reported that cTnT levels were higher in individuals with metabolic syndrome (MetS) than those without MetS, and elevated cTnT levels in individuals with MetS components or MetS were at greater risk of CAD. These findings highlighted the potential role of MetS, MetS components and possibly other cardiovascular risks when developing the cut-off criteria for CAD in sports settings. As a follow-on to the first contribution, Griffiths et al. 10 found that elevated cTnT levels in black participants were associated with more frequent and lengthier silent myocardial ischaemic events than with the matched white participants. Thus, the study also highlighted the role of ethnicity, and possibly gene polymorphisms. In addition, it is important to note that all the cTnT data of the two studies were sampled under resting conditions. The resting cTn levels have important prognostic significance, even within the 99 th percentile of a healthy reference population. 9, 10 These findings further emphasised the importance of resting cTn, which should be considered for incorporation into cut-off criteria in sports scenarios to optimise the diagnosis of subclinical CAD in athletes.
Combined, these studies [4] [5] [6] [7] [8] [9] [10] suggest that perhaps the cut-off value of cTn for the diagnosis of subclinical CAD in trained athletes needs to be individualised, rather than a single limited value. Clearly, all of this will need to be carefully tested in future studies before any conclusions for clinical practice can be proposed but, undoubtedly, the study by Skadberg and colleagues 3 is a good start.
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